A comprehensive exploration of adverse reactions to lapatinib: a disproportionate analysis based on the FAERS database
Lapatinib has a generally favorable safety profile, but gastrointestinal toxicity and dermatotoxicity require close monitoring to prevent serious AEs.
Authors
- Yao Zhou (ORCID: https://orcid.org/0000-0002-6527-9802)
- Anqi Ge (ORCID: https://orcid.org/0000-0001-7193-8985)
- Hongqiao Fan
- Shiting Wu (ORCID: https://orcid.org/0000-0002-3878-6526)
- Xianguang Deng (ORCID: https://orcid.org/0000-0002-4338-4601)
- Lele Shen
- Jie Gong (ORCID: https://orcid.org/0009-0001-1811-0940)
- Jie Ling
- Lifang Liu (ORCID: https://orcid.org/0009-0004-4274-4515)
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Hunan Academy of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1080/14740338.2025.2471515
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09